Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin

A. Ritchie (London, United Kingdom), S. Brill (London, United Kingdom), B. Vlies (Liverpool, United Kingdom), L. Finney (London, United Kingdom), J. Allinson (London, United Kingdom), L. Alves-Moreira (London, United Kingdom), P. Walker (Liverpool, United Kingdom), E. Baker (London, United Kingdom), S. Elkin (London, United Kingdom), P. Mallia (London, United Kingdom), G. Donaldson (London, United Kingdom), P. Calverley (Liverpool, United Kingdom), J. Wedzicha (London, United Kingdom)

Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session: COPD clinical studies: bronchodilators, corticosteroids and more
Session type: Poster Discussion
Number: 3386

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ritchie (London, United Kingdom), S. Brill (London, United Kingdom), B. Vlies (Liverpool, United Kingdom), L. Finney (London, United Kingdom), J. Allinson (London, United Kingdom), L. Alves-Moreira (London, United Kingdom), P. Walker (Liverpool, United Kingdom), E. Baker (London, United Kingdom), S. Elkin (London, United Kingdom), P. Mallia (London, United Kingdom), G. Donaldson (London, United Kingdom), P. Calverley (Liverpool, United Kingdom), J. Wedzicha (London, United Kingdom). Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin. 3386

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: